Thrombotic microangiopathy associated with humoral rejection of cardiac xenografts from α1,3-galactosyltransferase gene-knockout pigs in baboons

American Journal of Pathology

Volumn 172, Issue 6, 2008, Pages 1471-1481

  Shimizu, Akira ^a,c,d   Hisashi, Yosuke ^a   Kuwaki, Kenji ^a   Tseng, Yau Lin ^a   Dor, Frank J M F ^a   Houser, Stuart L ^a   Robson, Simon C ^b   Schuurman, Henk Jan ^c   Cooper, David K C ^a   Sachs, David H ^a   Yamada, Kazuhiko ^a   Colvin, Robert B ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Immerge Biotherapeutics Inc   (United States)

^d NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1,3 GALACTOSYLTRANSFERASE; CD3 ANTIGEN; CD39 ANTIGEN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4D; COMPLEMENT COMPONENT C5B; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; THROMBOPLASTIN; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BABOON; CARDIAC GRAFT REJECTION; COMPLEMENT DEPOSITION; CONTROLLED STUDY; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOCOMPATIBILITY; IMMUNOHISTOCHEMISTRY; KNOCKOUT GENE; NONHUMAN; PRIORITY JOURNAL; SWINE; T LYMPHOCYTE; THROMBOTIC THROMBOCYTOPENIC PURPURA; XENOGRAFT; XENOTRANSPLANTATION;

EID: 44849144688     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2008.070672     Document Type: Article

References (39)

1. Sachs DH, Sykes M, Robson SC, Cooper DK: Xenotransplantation. Adv Immunol 2001, 79:129-223
2. Samstein B, Platt JL: Physiologic and immunologic hurdles to xenotransplantation. J Am Soc Nephrol 2001, 12:182-193
3. Cooper DK, Gollackner B, Sachs DH: Will the pig solve the transplantation backlog? Annu Rev Med 2002, 53:133-147
4. Cooper DK: Clinical xenotransplantation - how close are we? Lancet 2003, 362:557-559
5. Bach FH, Robson SC, Winkler H, Ferran C, Stuhlmeier KM, Wrighton CJ, Hancock WW: Barriers to xenotransplantation. Nat Med 1995, 1:869-873
6. Good AH, Cooper DK, Malcolm AJ, Ippolito RM, Koren E, Neethling FA, Ye Y, Zuhdi N, Lamontagne LR: Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant Proc 1992, 24:559-562
7. Alwayn IP, Basker M, Buhler L, Cooper DK: The problem of anti-pig antibodies in pig-to-primate xenografting: current and novel methods of depletion and/or suppression of production of anti-pig antibodies. Xenotransplantation 1999, 6:157-168
8. Cozzi E, White DJ: The generation of transgenic pigs as potential organ donors for humans. Nat Med 1995, 1:964-966
9. Lambrigts D, Sachs DH, Cooper DK: Discordant organ xenotransplantation in primates: world experience and current status. Transplantation 1998, 66:547-561
10. Kozlowski T, Shimizu A, Lambrigts D, Yamada K, Fuchimoto Y, Glaser R, Monroy R, Xu Y, Awwad M, Colvin RB, Cosimi AB, Robson SC, Fishman J, Spitzer TR, Cooper DK, Sachs DH: Porcine kidney and heart transplantation in baboons undergoing a tolerance induction regimen and antibody adsorption. Transplantation 1999, 67:18-30
11. Zhong R, Luo Y, Yang H, Garcia B, Ghanekar A, Luke P, Chakrabarti S, Lajoie G, Phillips MJ, Katopodis AG, Duthaler RO, Cattral M, Wall W, Jevnikar A, Bailey M, Levy GA, Grant DR: Improvement in human decay accelerating factor transgenic porcine kidney xenograft rejection with intravenous administration of gas914, a polymeric form of alphaGAL. Transplantation 2003, 75:10-19
12. McGregor CG, Teotia SS, Byrne GW, Michaels MG, Risdahl JM, Schirmer JM, Tazelaar HD, Walker RC, Logan JS: Cardiac xenotransplantation: progress toward the clinic. Transplantation 2004, 78:1569-1575
13. Phelps CJ, Koike C, Vaught TD, Boone J, Wells KD, Chen SH, Ball S, Specht SM, Polejaeva IA, Monahan JA, Jobst PM, Sharma SB, Lamborn AE, Garst AS, Moore M, Demetris AJ, Rudert WA, Bottino R, Bertera S, Trucco M, Starzl TE, Dai Y, Ayares DL: Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 2003, 299:411-414
14. Kolber-Simonds D, Lai L, Watt SR, Denaro M, Arn S, Augenstein ML, Betthauser J, Carter DB, Greenstein JL, Hao Y, Im GS, Liu Z, Mell GD, Murphy CN, Park KW, Rieke A, Ryan DJ, Sachs DH, Forsberg EJ, Prather RS, Hawley RJ: Production of alpha-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations. Proc Natl Acad Sci USA 2004, 101:7335-7340
15. Kuwaki K, Tseng YL, Dor FJ, Shimizu A, Houser SL, Sanderson TM, Lancos CJ, Prabharasuth DD, Cheng J, Moran K, Hisashi Y, Mueller N, Yamada K, Greenstein JL, Hawley RJ, Patience C, Awwad M, Fishman JA, Robson SC, Schuurman HJ, Sachs DH, Cooper DK: Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med 2005, 11:29-31
16. Tseng YL, Kuwaki K, Dor FJ, Shimizu A, Houser S, Hisashi Y, Yamada K, Robson SC, Awwad M, Schuurman HJ, Sachs DH, Cooper DK: Alpha1,3- galactosyltransferase gene-knockout pig heart transplantation in baboons with survival approaching 6 months. Transplantation 2005, 80:1493-1500
17. Kuwaki K, Knosalla C, Dor FJ, Gollackner B, Tseng YL, Houser S, Mueller N, Prabharasuth D, Alt A, Moran K, Cheng J, Behdad A, Sachs DH, Fishman JA, Schuurman HJ, Awwad M, Cooper DK: Suppression of natural and elicited antibodies in pig-to-baboon heart transplantation using a human anti-human CD154 mAb-based regimen. Am J Transplant 2004, 4:363-372
18. Houser SL, Kuwaki K, Knosalla C, Dor FJ, Gollackner B, Cheng J, Shimizu A, Schuurman HJ, Cooper DK: Thrombotic microangiopathy and graft arteriopathy in pig hearts following transplantation into baboons. Xenotransplantation 2004, 11:416-425
19. Shimizu A, Yamada K, Yamamoto S, Lavelle JM, Barth RN, Robson SC, Sachs DH, Colvin RB: Thrombotic microangiopathic glomerulopathy in hDAF-transgenic swine-to-baboon kidney xenografts. J Am Soc Nephrol 2005, 16:2732-2745
20. Choo JK, Seebach JD, Nickeleit V, Shimizu A, Lei H, Sachs DH, Madsen JC: Species differences in the expression of major histocompatibility complex class II antigens on coronary artery endothelium: implications for cell-mediated xenoreactivity. Transplantation 1997, 64:1315-1322
21. Thiruvikraman SV, Guha A, Roboz J, Taubman MB, Nemerson Y, Fallon JT: In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X. Lab Invest 1996, 75:451-461
22. Gollackner B, Goh SK, Qawi I, Buhler L, Knosalla C, Daniel S, Kaczmarek E, Awwad M, Cooper DK, Robson SC: Acute vascular rejection of xenografts: roles of natural and elicited xenoreactive antibodies in activation of vascular endothelial cells and induction of procoagulant activity. Transplantation 2004, 77:1735-1741
23. Robson SC, Kaczmarek E, Siegel JB, Candinas D, Koziak K, Millan M, Hancock WW, Bach FH: Loss of ATP diphosphohydrolase activity with endothelial cell activation. J Exp Med 1997, 185:153-163
24. Shimizu A, Meehan SM, Kozlowski T, Sablinski T, Ierino FL, Cooper DK, Sachs DH, Colvin RB: Acute humoral xenograft rejection: destruction of the microvascular capillary endothelium in pig-to-nonhuman primate renal grafts. Lab Invest 2000, 80:815-830
25. Stewart S, Winters GL, Fishbein MC, Tazelaar HD, Kobashigawa J, Abrams J, Andersen CB, Angelini A, Berry GJ, Burke MM, Demetris AJ, Hammond E, Itescu S, Marboe CC, McManus B, Reed EF, Reinsmoen NL, Rodriguez ER, Rose AG, Rose M, Suciu-Focia N, Zeevi A, Billingham ME: Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005, 24:1710-1720
26. Rose AG, Cooper DK: A histopathologic grading system of hyperacute (humoral, antibody-mediated) cardiac xenograft and allograft rejection. J Heart Lung Transplant 1996, 15:804-817
27. Schuurman HJ, Cheng J, Lam T: Pathology of xenograft rejection: a commentary. Xenotransplantation 2003, 10:293-233
28. Shimizu A, Colvin RB: Pathological features of antibody-meditated rejection. Curr Drug Targets-Cardiovasc Haemat Dis 2005, 5:199-214
29. Knosalla C, Gollackner B, Cooper DKC: Anti-CD154 monoclonal antibody and thromboembolism revisited. Transplantation 2002, 74:416-417
30. Buhler L, Xu Y, Li W, Zhu A, Cooper DK: An investigation of the specificity of induced anti-pig antibodies in baboons. Xenotransplantation 2003, 10:88-93
31. Lam TT, Paniagua R, Shivaram G, Schuurman HJ, Borie DC, Morris RE: Anti-non-Gal porcine endothelial cell antibodies in acute humoral xenograft rejection of hDAF-transgenic porcine hearts in cynomolgus monkeys. Xenotransplantation 2004, 11:531-535
32. Chen G, Qian H, Starzl T, Sun H, Garcia B, Wang X, Wise Y, Liu Y, Xiang Y, Copeman L, Liu W, Jevnikar A, Wall W, Cooper DK, Murase N, Dai Y, Wang W, Xiong Y, White DJ, Zhong R: Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat Med 2005, 11:1295-1298
33. Zhu A, Hurst R: Anti-N-glycolylneuraminic acid antibodies identified in healthy human serum. Xenotransplantation 2002, 9:376-381
34. Ezzelarab M, Ayares D, Cooper DK: Carbohydrates in xenotransplantation. Immunol Cell Biol 2005, 83:396-404
35. Holzknecht ZE, Kuypers KL, Plummer TB, Williams J, Bustos M, Gores GJ, Brunn GJ, Platt JL: Apoptosis and cellular activation in the pathogenesis of acute vascular rejection. Circ Res 2002, 91:1135-1141
36. Saadi S, Holzknecht RA, Patte CP, Stern DM, Platt JL: Complement-mediated regulation of tissue factor activity in endothelium. J Exp Med 1995, 182:1807-1814
37. Platt JL: The immunological barriers to xenotransplantation. Crit Rev Immunol 1996, 16:331-358
38. Robson SC, Schulte am Esch II J, Bach FH: Factors in xenograft rejection. Ann NY Acad Sci 1999, 875:261-276
39. Yamada K, Yazawa K, Shimizu A, Iwanaga T, Hisashi Y, Nuhn M, O'Malley P, Nobori S, Vagefi PA, Patience C, Fishman J, Cooper DK, Hawley RJ, Greenstein J, Schuurman HJ, Awwad M, Sykes M, Sachs DH: Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med 2005, 11:32-34